Allen Roses, Director, Deane Drug Discovery Institute, Duke University
Mr. Roses talks about his experience in creating virtual companies —– companies designed to help bridge the gap between large companies (which often make poor decisions because they lack sufficient understanding of new opportunities) and academia (which typically lacks funding).
Dx2010 Markers to Market brought together leading international researchers, regulatory representatives and entrepreneurs from the diagnostics sector to examine regulatory hurdles and commercialization challenges on the path from biomarker discovery to market for molecular diagnostics and prognostics. Dx2010 Markers to Market was co-hosted by the Ontario Genomics Institute and MaRS.
MaRS - Building Canada’s next generation of global technology companies. marsdd.com